Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NasdaqGS:AMGN
Amgen
|
314.72 | -12,88% | -4,16% | 168.826,73 | 2,82% | 5,31% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
967.98 | -28,55% | -22,46% | 104.431,01 | 0% | 13,9% |
|
SWX:LONN
Lonza Group
|
527.40 | -28,27% | -13,17% | 38.034,29 | 0,75% | 0,68% |
|
NYSE:CTLT
Catalent
|
55.25 | -57,27% | -6,76% | 10.100,49 | 0% | -10,41% |
|
SEHK:2269
WuXi Biologics (Cayman)
|
14.56 | 1.252,89% | 1.640,1% | 60.693,6 | 0% | 56,6% |
|
KOSDAQ:A068760
Celltrion Pharm
|
98700.00 | 0% | 0% | 4.000.182,53 | 0% | 0% |
|
XTRA:EVT
Evotec
|
10.27 | -32,05% | 101,29% | 1.726,81 | 0% | 0% |
|
NasdaqCM:CDMO
Avid Bioservices
|
9.20 | -62,95% | 23,5% | 484,35 | 0% | 20,6% |
